Bauer, A. ; Zierer, A. ; Gieger, C. ; Büyüközkan, M. ; Müller-Nurasyid, M. ; Grallert, H. ; Meisinger, C. ; Strauch, K. ; Prokisch, H. ; Roden, M.* ; Peters, A. ; Krumsiek, J. ; Herder, C. ; Koenig, W.* ; Thorand, B. ; Huth, C.
Comparison of genetic risk prediction models to improve prediction of coronary heart disease in two large cohorts of the MONICA/KORA study.
Genet. Epidemiol. 45, 633-650 (2021)
It is still unclear how genetic information, provided as single-nucleotide polymorphisms (SNPs), can be most effectively integrated into risk prediction models for coronary heart disease (CHD) to add significant predictive value beyond clinical risk models. For the present study, a population-based case-cohort was used as a trainingset (451 incident cases, 1488 noncases) and an independent cohort as testset (160 incident cases, 2749 noncases). The following strategies to quantify genetic information were compared: A weighted genetic risk score including Metabochip SNPs associated with CHD in the literature (GRSMetabo ); selection of the most predictive SNPs among these literature-confirmed variants using priority-Lasso (PLMetabo ); validation of two comprehensive polygenic risk scores: GRSGola based on Metabochip data, and GRSKhera (available in the testset only) based on cross-validated genome-wide genotyping data. We used Cox regression to assess associations with incident CHD. C-index, category-free net reclassification index (cfNRI) and relative integrated discrimination improvement (IDIrel ) were used to quantify the predictive performance of genetic information beyond Framingham risk score variables. In contrast to GRSMetabo and PLMetabo , GRSGola significantly improved the prediction (delta C-index [95% confidence interval]: 0.0087 [0.0044, 0.0130]; IDIrel : 0.0509 [0.0131, 0.0894]; cfNRI improved only in cases: 0.1761 [0.0253, 0.3219]). GRSKhera yielded slightly worse prediction results than GRSGola .
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Framingham Risk Score ; Metabochip ; Coronary Heart Disease ; Genomic Risk Prediction ; Priority-lasso; Myocardial-infarction; Clinical Utility; Artery-disease; Scores; Association; Imputation; Accuracy; Events; Loci; Architecture
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
HGF-Berichtsjahr
2021
ISSN (print) / ISBN
0741-0395
e-ISSN
1098-2272
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 45,
Heft: 6,
Seiten: 633-650
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Wiley
Verlagsort
111 River St, Hoboken 07030-5774, Nj Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30202 - Environmental Health
30205 - Bioengineering and Digital Health
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
Forschungsfeld(er)
Genetics and Epidemiology
Enabling and Novel Technologies
PSP-Element(e)
G-504000-006
G-504090-001
G-504000-002
G-504000-010
G-504091-004
G-554100-001
G-504100-001
G-504091-002
G-502900-001
G-500700-001
G-503292-001
Förderungen
Helmholtz Zentrum Munchen
Ludwig-Maximilians-Universitat Munchen
German Federal Ministry of Health
Bavarian State Ministry of Health and Care (DigiMed Bayern)
German Federal Ministry of Education and Research
Ministry of Culture and Science of the State of North Rhine-Westphalia
Helmholtz Alliance 'Aging and Metabolic Programming, AMPro'
Deutsche Forschungsgemeinschaft
Copyright
Erfassungsdatum
2021-07-06